Trade Summary

3 days ago, Lucera Erick, serving as Chief Financial Officer at Dyne Therapeutics, Inc. (DYN), sold 2,362 shares at $20.37 per share, for a total transaction value of $48,113.94. Following this transaction, Lucera Erick now holds 121,563 shares of DYN.

This sale represents a 1.91% decrease in Lucera Erick's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 4:15 PM ET, 1 day after the trade was made.

Dyne Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.